논문 및 지식재산

연구 프로그램의 과학적 근거

면역 신호전달과 재생 펩타이드 연구를 대표하는 논문과 원문 DOI 링크를 제공합니다.

01
TLR9 agonistic DNA aptamer

Molecular and functional characterization of a novel Toll-like receptor 9-specific DNA aptamer with therapeutic potential

Farooq et al. · International Immunopharmacology · 2026 · 172:116134

DOI 보기
02
MyD88 inhibitory peptide

Rational design and therapeutic potential of MyD88 inhibitory peptide in psoriasis

Farooq et al. · Biomedicine & Pharmacotherapy · 2025 · 183:117801

DOI 보기
03
NLRP3 억제

Novel Small-Molecule Inhibitor of NLRP3 Inflammasome Reverses Cognitive Impairment in an Alzheimer's Disease Model

Haseeb et al. · ACS Chemical Neuroscience · 2022 · 13(6):818–833

DOI 보기
04
Endosomal TLR 억제

Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases

Jeong et al. · Experimental & Molecular Medicine · 2025 · 57:1951–1962

DOI 보기
05
FGFR agonistic peptide

Identification of a novel fibroblast growth factor receptor-agonistic peptide and its effect on diabetic wound healing

Farooq et al. · Life Sciences · 2025 · 364:123432

DOI 보기
06
VEGFR2 agonistic peptide

AI-assisted design of a VEGFR2 agonistic peptide that promotes angiogenesis and wound repair

Yasmeen et al. · Protein Science · 2026 · e70529

DOI 보기
07
Substance P analog

Endogenous Stem Cell-Based In Situ Tissue Regeneration Using Electrostatically Interactive Hydrogel with a Newly Discovered Substance P Analog and VEGF-Mimicking Peptide

Park et al. · Small · 2021 · 17(40):e2103244

DOI 보기
08
SDF-1 mimetic peptide

In-situ wound healing by SDF-1-mimic peptide-loaded click crosslinked hyaluronic acid scaffold

Kim et al. · Journal of Controlled Release · 2023 · 364:420–434

DOI 보기
지식재산

프로그램별 지식재산 논의

협력 가능성을 검토할 때 특정 프로그램과 관련된 지식재산을 논의할 수 있습니다. 논문의 공개만으로 회사의 권리 보유, 기술이전 가능성 또는 독점성이 확정되는 것은 아닙니다.

프로그램 논의하기